Works matching DE "PHENTERMINE (Drug)"

Results: 106

Pharmacotherapy for Obesity.

Published in:

Journal of Menopausal Medicine, 2020, v. 26, n. 2, p. 90, doi. 10.6118/jmm.2014.20.3.90

By:

Jong Kil Joo;
Kyu Sup Lee

Publication type:

Article

Combination phentermine and topiramate effective obesity therapy.

Published in:: Australian Journal of Pharmacy, 2011, v. 92, n. 1097, p. 81
Publication type:: Article

The fat of the matter.

Published in:: Nature Medicine, 2012, v. 18, n. 8, p. 1155, doi. 10.1038/nm.2912
Publication type:: Article

Combination phentermine and topiramate for weight maintenance: the first Australian experience.

Published in:

Medical Journal of Australia, 2014, v. 201, n. 4, p. 224, doi. 10.5694/mja13.00193

By:

Neoh, Sandra L.;
Sumithran, Priya;
Haywood, Cilla J.;
Houlihan, Christine A.;
Lee, Fiona T. H.;
Proietto, Joseph

Publication type:

Article

Early warning about fen-phen.

Published in:

Physician & Sportsmedicine, 1997, v. 25, n. 8, p. 47

By:

Beran, Eileen R.

Publication type:

Article

Tracking the `fenphen' drug trend.

Published in:: Physician & Sportsmedicine, 1996, v. 24, n. 9, p. 17, doi. 10.3810/psm.1996.09.1525
Publication type:: Article

EFFECTS OF ANORECTIC DRUGS ON FOOD INTAKE UNDER PROGRESSIVE-RATIO AND FREE-ACCESS CONDITIONS IN RATS.

Published in:

Journal of the Experimental Analysis of Behavior, 2004, v. 82, n. 3, p. 275, doi. 10.1901/jeab.2004.82-275

By:

LeSage, Mark G.;
Stafford, David;
Glowa, John R.

Publication type:

Article

Vasospastic myocardial infarction caused by a slimming agent--do not forget non-prescription drugs.

Published in:

2017

By:

Anwar, Mohammed Omer;
Bodagh, Neil;
Iqbal, Mohammed Husnain;
Timmis, Adam

Publication type:

Case Study

Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report.

Published in:

2019

By:

Hyun-Sic Jo;
Sheng-Min Wang;
Jung Jin Kim

Publication type:

Case Study

Phentermine, Sibutramine and Affective Disorders.

Published in:

Clinical Psychopharmacology & Neuroscience, 2013, v. 11, n. 1, p. 7, doi. 10.9758/cpn.2013.11.1.7

By:

An, Hoyoung;
Sohn, Hyunjoo;
Chung, Seockhoon

Publication type:

Article

HPLC OF (±)-FENFLURAMINE AND PHENTERMINE IN PLASMA AFTER DERIVATIZATION WITH DANSYL CHLORIDE.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2001, v. 24, n. 1, p. 57, doi. 10.1081/JLC-100000326

By:

Kaddoumi, Amal;
Nakashima, MihokoN.;
Wada, Mitsuhiro;
Kuroda, Naotaka;
Nakahara, Yuji;
Nakashima, Kenichiro

Publication type:

Article

Open Treatment of Overweight Binge Eaters with Phentermine and Fluoxetine as an Adjunct to Cognitive-Behavioral Therapy.

Published in:

International Journal of Eating Disorders, 2000, v. 28, n. 3, p. 325, doi. 10.1002/1098-108X(200011)28:3<325::AID-EAT10>3.0.CO;2-3

By:

Devlin, Michael J.;
Goldfein, Juli A.

Publication type:

Article

Lower Dosages of Phentermine-Fenfluramine Given in the Afternoon: Five Cases with Significant...

Published in:

International Journal of Eating Disorders, 1999, v. 25, n. 4, p. 469, doi. 10.1002/(SICI)1098-108X(199905)25:4<469::AID-EAT13>3.0.CO;2-H

By:

Katz, Debra A.;
Maloney, Michael J.

Publication type:

Article

Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens.

Published in:

Psychopharmacology, 2016, v. 233, n. 8, p. 1405, doi. 10.1007/s00213-016-4231-z

By:

Hong, Sa-Ik;
Kim, Min-Jung;
You, In-Jee;
Kwon, Seung-Hwan;
Ma, Shi-Xun;
Hwang, Ji-Young;
Seo, Jee-Yeon;
Ko, Yong-Hyun;
Lee, Bo;
Lee, Seok-Yong;
Jang, Choon-Gon

Publication type:

Article

Investigating interactions between phentermine, dexfenfluramine, and 5-HT agonists, on food intake in the rat.

Published in:

Psychopharmacology, 2015, v. 232, n. 11, p. 1973, doi. 10.1007/s00213-014-3829-2

By:

Grottick, Andrew;
Whelan, Kevin;
Sanabria, Erin;
Behan, Dominic;
Morgan, Michael;
Sage, Carleton

Publication type:

Article

Cost-Effectiveness Analysis of Qsymia for Weight Loss.

Published in:

PharmacoEconomics, 2015, v. 33, n. 7, p. 699, doi. 10.1007/s40273-014-0182-6

By:

Finkelstein, Eric;
Kruger, Eliza;
Karnawat, Sunil

Publication type:

Article

Specific Medications for Weight Loss.

Published in:

JAMA: Journal of the American Medical Association, 2015, v. 314, n. 7, p. 742, doi. 10.1001/jama.2015.5836

By:

Jin, Jill

Publication type:

Article

Fentermina y topiramato contra fentermina más placebo en pacientes con sobrepeso u obesidad clase I o II.

Published in:

Medicina Interna de Mexico, 2015, v. 31, n. 2, p. 125

By:

Hernández-Bastida, Antonio

Publication type:

Article

Additive effects on rat brain 5HT release of combining phentermine with dexfenfluramine.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, n. 10, p. 1450, doi. 10.1038/sj.ijo.0801717

By:

Prow, M R;
Lancashire, B;
Aspley, S;
Heal, D J;
Kilpatrick, I C

Publication type:

Article

Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 2001, v. 25, n. 10, p. 1454, doi. 10.1038/sj.ijo.0801732

By:

Kilpatrick, I C;
Traut, M;
Heal, D J

Publication type:

Article

Initial weight loss as a predictor of response to obesity drugs.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 1999, v. 23, n. 12, p. 1333, doi. 10.1038/sj.ijo.0801111

By:

Dhurandhar, N V;
Blank, R C;
Schumacher, D;
Atkinson, R L

Publication type:

Article

Synergistic interactions between Fenfluramine and Phentermine.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 1999, v. 23, n. 7, p. 723, doi. 10.1038/sj.ijo.0800920

By:

Wellman, P J;
Maher, T J

Publication type:

Article

Effects of phentermine on striatal dopamine and serotonin release in conscious rats:In vivo microdialysis study.

Published in:

International Journal of Obesity & Related Metabolic Disorders, 1998, v. 22, n. 4, p. 325, doi. 10.1038/sj.ijo.0800589

By:

Balcioglu, A;
Wurtman, R J

Publication type:

Article

Pharmacologic Induction of Weight Loss to Treat Type 2 Diabetes.

Published in:

Diabetes Care, 1999, v. 22, n. 6, p. 896, doi. 10.2337/diacare.22.6.896

By:

Redmon, J. Bruce;
Raatz, Susan K.;
Kwong, Christine A.;
Swanson, Joyce E.;
Thomas, William;
Bantle, John P.

Publication type:

Article

RE: Pulmonary Hypertension Associated with Use of Phentermine?

Published in:

Yonsei Medical Journal, 2011, v. 52, n. 5, p. 869, doi. 10.3349/ymj.2011.52.5.869

By:

Hendricks, Ed J.;
Rothman, Richard B.

Publication type:

Article

Pulmonary Hypertension Associated with Use of Phentermine.

Published in:

Yonsei Medical Journal, 2010, v. 51, n. 6, p. 971, doi. 10.3349/ymj.2010.51.6.971

By:

Woo-Dae Bang;
Ji-Ye Kim;
Hee-Tae Yu;
Sung-Soo Cho;
Ji-Yong Jang;
Chang-Myung Oh;
Boyoung Joung;
Hyuk-Jae Chang

Publication type:

Article

Use of Prescription Antiobesity Drugs in the United States.

Published in:

Pharmacotherapy, 2013, v. 33, n. 12, p. 1299, doi. 10.1002/phar.1342

By:

Hampp, Christian;
Kang, Elizabeth M.;
Borders‐Hemphill, Vicky

Publication type:

Article

Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs.

Published in:

Pharmacotherapy, 2013, v. 33, n. 12, p. 1308, doi. 10.1002/phar.1277

By:

Ling, Hua;
Lenz, Thomas L.;
Burns, Tammy L.;
Hilleman, Daniel E.

Publication type:

Article

Market watch: Upcoming market catalysts in Q2 2012.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 260, doi. 10.1038/nrd3707

By:

Akie, William

Publication type:

Article

Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2017, v. 32, n. 1, p. 1253, doi. 10.1080/14756366.2017.1375485

By:

Angeli, Andrea;
Vaiano, Fabio;
Mari, Francesco;
Bertol, Elisabetta;
Supuran, Claudiu T.

Publication type:

Article

Impact of Weight Loss on Serum Leptin in Obese Postmenopausal Women.

Published in:

Journal of Applied Research, 2004, v. 4, n. 1, p. 60

By:

Cordero-MacIntyre, Zaida R.;
Metghalchi, Shiva;
Rosen, Jason;
Peters, Warren;
Lohman, Timothy G.;
Fernandez, Maria Luz

Publication type:

Article

Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review.

Published in:

World Journal of Men's Health, 2021, v. 39, n. 2, p. 208, doi. 10.5534/wjmh.200010

By:

Tak, Young Jin;
Lee, Sang Yeoup

Publication type:

Article

Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.

Published in:

Psychopharmacology, 1998, v. 137, n. 1, p. 99, doi. 10.1007/s002130050598

By:

Roth, Jonathan D.;
Rowland, N. E.

Publication type:

Article

Behavioural and neurochemical characteristics of phentermine and fenfluramine administered separately and as a mixture in rats.

Published in:

Psychopharmacology, 1997, v. 131, n. 3, p. 296, doi. 10.1007/s002130050296

By:

Shoaib, M.;
Baumann, Michael H.;
Rothman, Richard B.;
Goldberg, Steven R.;
Schindler, Charles W.

Publication type:

Article

Health advisory on concomitant fenfluramine and phentermine use.

Published in:: JAMA: Journal of the American Medical Association, 1997, v. 278, n. 5, p. 379
Publication type:: Article

Pharmacotherapy for Obesity and Weight Loss.

Published in:

South Dakota Medicine, 2013, v. 66, n. 11, p. 471

By:

Rhines, Spenser D.;
Heins, Jodi R.

Publication type:

Article

Two New Drugs Approved for Obesity.

Published in:

South Dakota Medicine, 2012, v. 65, n. 9, p. 356

By:

Johnson, Annette M.

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist.

Published in:

Journal of Clinical Pharmacology, 2009, v. 49, n. 10, p. 1228, doi. 10.1177/0091270009341651

By:

Addy, Carol;
Jumes, Patricia;
Rosko, Kimberly;
Li, Susie;
Li, Hankun;
Maes, Andrea;
Johnson-Levonas, Amy O.;
Chodakewitz, Jeffrey;
Stoch, S. Aubrey;
Wagner, John A.

Publication type:

Article

Drugs to treat obesity: do they work?

Published in:

2016

By:

Kim, Sarah

Publication type:

journal article

Combination therapy for obesity.

Published in:

2017

By:

Wilding, John P. H.;
Wilding, John Ph

Publication type:

journal article

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Published in:

Expert Review of Cardiovascular Therapy, 2010, v. 8, n. 12, p. 1777, doi. 10.1586/ERC.10.125

By:

Bays, Harold

Publication type:

Article

Colon Ischemia After Weight-Loss Medication in a 36-Year-Old Woman.

Published in:

Connecticut Medicine, 2016, v. 80, n. 4, p. 213

By:

SHARMA, PRABIN;
KRISHNAMOORTHY, PARASURAM

Publication type:

Article

Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data?

Published in:

Acta Diabetologica, 2017, v. 54, n. 8, p. 715, doi. 10.1007/s00592-017-0994-x

By:

Roberts, Carl;
Christiansen, Paul;
Halford, Jason

Publication type:

Article

Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?

Published in:

2016

By:

Kolotkin, Ronette;
Gadde, Kishore;
Peterson, Craig;
Crosby, Ross;
Kolotkin, Ronette L;
Gadde, Kishore M;
Peterson, Craig A;
Crosby, Ross D

Publication type:

journal article

Pharmacotherapy in the Treatment of Obesity.

Published in:

Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2016, v. 23, n. 4, p. 415, doi. 10.1515/rjdnmd-2016-0048

By:

Ionică, Floriana Elvira;
Negreș, Simona;
Șeremet, Oana Cristina;
Chiriță, Cornel

Publication type:

Article

Update in General Internal Medicine: Evidence Published in 2012.

Published in:

Annals of Internal Medicine, 2013, v. 158, n. 8, p. 615, doi. 10.7326/0003-4819-158-8-201304160-00101

By:

Rusk, Matthew;
Cato, Robert K.

Publication type:

Article

Amfepramone: new cases of primary pulmonary hypertension.

Published in:: WHO Drug Information, 2001, v. 15, n. 1, p. 24
Publication type:: Article

Poster Session II (PII 1–88).

Published in:: 2011
Publication type:: Abstract

Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 10, p. 3019, doi. 10.1210/clinem/dgab408

By:

Elkind-Hirsch, Karen E.;
Chappell, N.;
Seidemann, Ericka;
Storment, John;
Bellanger, Drake

Publication type:

Article

Update on pharmacology of obesity: Benefits and risks.

Published in:

Nutrición Hospitalaria, 2013, v. 28, p. 121, doi. 10.3305/nh.2013.28.sup5.6869

By:

Cabrerizo García, Lucio;
Ramos-Leví, Ana;
Moreno Lopera, Carmen;
Rubio Herrera, Miguel A.

Publication type:

Article